|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Accretion of debt discount and amortization of debt issuance costs | |||||
| Amortization (accretion) of purchased investment premium or discount, net | |||||
| Net foreign currency and other gain | |||||
| Stock-based compensation expense | |||||
| Write-off of capitalized software | |||||
| Deferred income taxes | |||||
| Bad debt expense | |||||
| Changes in operating assets and liabilities, net of acquisitions: | |||||
| Accounts receivable | |||||
| Deferred commissions | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Deferred revenue | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of marketable investments | |||||
| Purchases of non-marketable investments | |||||
| Maturities and sales of investments | |||||
| Capital expenditures | |||||
| Capitalized software costs | |||||
| Cash paid for acquisitions, net of cash acquired | |||||
| Other, net | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from term loan debt, net of discount | |||||
| Payments of debt issuance and modification costs | |||||
| Repayment of debt | |||||
| Principal payments under capital lease obligations | |||||
| Proceeds from employee stock plans | |||||
| Repurchases of common stock | |||||
| Payment of tax withholdings for employee stock plans | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| Net (decrease) increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period1 | |||||
| Supplemental cash flow data | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Proceeds from employee stock plans received in advance of stock issuance | |||||
| Non-cash investing and financing activities: | |||||
| Assets acquired under capital leases and other financing arrangements | |||||
| Capitalized assets financed by accounts payable and accrued expenses | |||||
| Capitalized stock-based compensation | |||||
| Deferred debt issuance costs included in accrued expenses | |||||
| Unsettled share repurchase in other liabilities | |||||
| Issuance of common stock for partial consideration for acquisition | |||||
| Increase in debt discount as a result of modification of Convertible Notes | |||||
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | |||||
| Cash and cash equivalents | |||||
| Restricted cash included in prepaid expenses and other current assets | |||||
| Restricted cash included in other assets | |||||
Loading...